<link rel="stylesheet" href="/res/styles.39be4579664c3a48.css">
Artículo

Where Self Meets Gluten in the Birth of Transglutaminase Autoantibodies in Celiac Disease

Chirdo, Fernando Gabriel Icon; Anderson, Robert P.

Otros responsables

Fecha

12/2025

Editorial

W B Saunders Co-Elsevier Inc

Revista

Gastroenterology

Título del libro

Nombre del evento

Fecha del evento

Institución organizadora

ISSN

0016-5085

eISSN

ISBN

Idioma

Inglés

Tipo del evento

Clasificación temática

Palabras clave

Resumen

C eliac disease (CeD) is an unfortunate and perhapsinevitable consequence of our reliance on wheat,rye, and barley to provide substantial sources of dietaryprotein and carbohydrate. Approximately 1% of populationsconsuming wheat, rye, and barley are affected byCeD.1 Despite growing public and medical awareness overthe last 2 decades, unrecognized, misdiagnosed, andpersistently active CeD continues to be a common publichealth issue.1The biology of transglutaminase 2 (TG2) has played anunexpected but profound role in understanding and managingCeD. TG2 expression is low in the healthy intestinalmucosa, but cytosolic TG2 is released during apoptosis andepithelial shedding, and its expression in the gut isenhanced by injury and innate immune stimuli.2 TG2 catalyzesthe release of ammonia (deamidation) from selectedglutamine residues in peptides and proteins, includinggluten. The product of this posttranslational modification isglutamate in acidic conditions, or in neutral and mildlyalkaline conditions, a covalent (isopeptide) bond is formedbetween glutamate and an amine donor.

Colecciones

Aprobación

Revisión

Complementado por

Referenciado por

Licencia Creative Commons

Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa